TY - JOUR
T1 - Differences in the epidemiology, management and outcomes of kidney disease in men and women
AU - Chesnaye, Nicholas C.
AU - Carrero, Juan Jesus
AU - Hecking, Manfred
AU - Jager, Kitty J.
N1 - Publisher Copyright: © 2023, Springer Nature Limited.
PY - 2024/1
Y1 - 2024/1
N2 - Improved understanding of differences in kidney disease epidemiology, management and outcomes in men and women could help nephrologists to better meet the needs of their patients from a sex- and gender-specific perspective. Evidence of sex differences in the risk and outcomes of acute kidney injury is mixed and dependent on aetiology. Women have a higher prevalence of chronic kidney disease (CKD) stages 3–5 than men, whereas men have a higher prevalence of albuminuria and hence CKD stages 1–2. Men show a faster decline in kidney function, progress more frequently to kidney failure and have higher mortality and risk of cardiovascular disease than women. However, the protective effect of female sex is reduced with CKD progression. Women are less likely than men to be aware of, screened for and diagnosed with CKD, started on antiproteinuric medication and referred to nephrologist care. They also consistently report a poorer health-related quality of life and a higher symptom burden than men. Women experience greater barriers than men to access the waiting list for kidney transplantation, particularly with respect to older age and obesity. However, women also have longer survival than men after transplantation, which may partly explain the comparable prevalence of transplantation between the sexes.
AB - Improved understanding of differences in kidney disease epidemiology, management and outcomes in men and women could help nephrologists to better meet the needs of their patients from a sex- and gender-specific perspective. Evidence of sex differences in the risk and outcomes of acute kidney injury is mixed and dependent on aetiology. Women have a higher prevalence of chronic kidney disease (CKD) stages 3–5 than men, whereas men have a higher prevalence of albuminuria and hence CKD stages 1–2. Men show a faster decline in kidney function, progress more frequently to kidney failure and have higher mortality and risk of cardiovascular disease than women. However, the protective effect of female sex is reduced with CKD progression. Women are less likely than men to be aware of, screened for and diagnosed with CKD, started on antiproteinuric medication and referred to nephrologist care. They also consistently report a poorer health-related quality of life and a higher symptom burden than men. Women experience greater barriers than men to access the waiting list for kidney transplantation, particularly with respect to older age and obesity. However, women also have longer survival than men after transplantation, which may partly explain the comparable prevalence of transplantation between the sexes.
UR - http://www.scopus.com/inward/record.url?scp=85177193025&partnerID=8YFLogxK
U2 - https://doi.org/10.1038/s41581-023-00784-z
DO - https://doi.org/10.1038/s41581-023-00784-z
M3 - Review article
C2 - 37985869
SN - 1759-5061
VL - 20
SP - 7
EP - 20
JO - Nature Reviews Nephrology
JF - Nature Reviews Nephrology
IS - 1
ER -